Rilpivirine-13C6
Rilpivirine-13C6 (R278474-13C6) is 13C labeled Rilpivirine. Rilpivirine (R278474) is a potent and specific diarylpyrimidine (DAPY) non-nucleoside reverse transcriptase inhibitor (NNRTI) . Rilpivirine has high antiviral activity against wild-type HIV (EC50=0.4 nM) and mutant viruses (EC50=0.1-2.0 nM) . Rilpivirine has a high genetic barrier to resistance development of HIV[1][2].
Product Specifications
Product Name Alternative
R278474-13C6; TMC278-13C6; DB08864-13C6
UNSPSC
12352005
Target
HIV; Isotope-Labeled Compounds; Reverse Transcriptase
Related Pathways
Anti-infection; Others
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
CC1=CC(/C=C/C#N)=CC(C)=C1NC2=CC=NC(N[13C]3=[13CH][13CH]=[13C]([13CH]=[13CH]3)C#N)=N2
Molecular Formula
C16 13C6H18N6
Molecular Weight
372.37
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Janssen PAJ, et, al. In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[ (1E) -2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine) . J Med Chem. 2005 Mar 24;48 (6) :1901-9.|[3]Azijn H, et, al. TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1. Antimicrob Agents Chemother. 2010 Feb;54 (2) :718-27.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402349-100 1x 100 µL
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUM2463-50 1x 50 µL
Ki-67 (Proliferating Cell Marker) (MKI67/2463), 1mg/mL
Sign In for Pricing
View Details 